Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0G2IC
|
|||
Former ID |
DNC005788
|
|||
Drug Name |
(S)-FLURBIPROFEN
|
|||
Synonyms |
51543-39-6; esflurbiprofen; (S)-(+)-2-Fluoro-alpha-methyl-4-biphenylacetic acid; UNII-J5ZZK9P7MX; (S)-2-(2-fluorobiphenyl-4-yl)propanoic acid; (S)-2-(2-Fluoro-[1,1'-biphenyl]-4-yl)propanoic acid; (2S)-2-(2-fluorobiphenyl-4-yl)propanoic acid; J5ZZK9P7MX; CHEMBL435298; CHEBI:42446; SYTBZMRGLBWNTM-JTQLQIEISA-N; (2S)-2-(3-fluoro-4-phenylphenyl)propanoic acid; BTS-24332; (S)-2-Fluoro-alpha-methyl-4-biphenylacetic acid; (S)-2-Fluoro-alpha-methyl(1,1'-biphenyl)-4-acetic ac
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Myalgia [ICD-11: FB56.2; ICD-10: M79.1] | Preregistration | [1] | |
Osteoarthritis [ICD-11: FA00-FA05] | Preregistration | [1] | ||
Scapulohumeral periarthritis [ICD-11: FB53] | Preregistration | [1] | ||
Company |
Taisho Pharmaceutical; TOKUHON
|
|||
Structure |
Download2D MOL |
|||
Formula |
C15H13FO2
|
|||
Canonical SMILES |
CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O
|
|||
InChI |
1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)/t10-/m0/s1
|
|||
InChIKey |
SYTBZMRGLBWNTM-JTQLQIEISA-N
|
|||
CAS Number |
CAS 51543-39-6
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:42446
|
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025057) | |||
REF 2 | The geminal dimethyl analogue of Flurbiprofen as a novel Abeta42 inhibitor and potential Alzheimer's disease modifying agent. Bioorg Med Chem Lett. 2006 Apr 15;16(8):2219-23. | |||
REF 3 | 2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors. J Med Chem. 2005 Jun 30;48(13):4312-31. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.